An interactive Bayesian model for prediction of lymph node ratio and survival in pancreatic cancer patients

Por Smith, Brian J, Mezhir, James J
Publicado em 2014

The Impact of Sarcopenia on Survival and Complications in Surgical Oncology: A Review of the Current Literature

Por JOGLEKAR, SAVITA, NAU, PETER N., MEZHIR, JAMES J.
Publicado no J Surg Oncol (2015)

Rational design of a secreted enzymatically inactive mutant of extracellular superoxide dismutase

Por Case, Adam J., Mezhir, James J., O'Leary, Brianne R., Hrabe, Jennifer E., Domann, Frederick E.
Publicado em 2013

Prolyl-4-Hydroxylase 3 (PHD3) Expression Is Downregulated during Epithelial-to-Mesenchymal Transition

Por Place, Trenton L., Nauseef, Jones T., Peterson, Maina K., Henry, Michael D., Mezhir, James J., Domann, Frederick E.
Publicado em 2013

Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients

Por Mezhir, James J., Shah, Manish A., Jacks, Lindsay M., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
Publicado em 2011

A Comprehensive Assessment of Transfusion in Elective Pancreatectomy: Risk Factors and Complications

Por Sun, Raphael C., Button, Anna M., Smith, Brian J., Leblond, Richard F., Howe, James R., Mezhir, James J.
Publicado no J Gastrointest Surg (2013)

Sarcopenia Is an Independent Predictor of Complications Following Pancreatectomy for Adenocarcinoma

Por JOGLEKAR, SAVITA, ASGHAR, AEEN, MOTT, SARAH L., JOHNSON, BENJAMIN E., BUTTON, ANNA M., CLARK, EVE, MEZHIR, JAMES J.
Publicado no J Surg Oncol (2014)

Pancreatectomy Predicts Improved Survival for Pancreatic Adenocarcinoma: Results of an Instrumental Variable Analysis

Por McDowell, Bradley D., Chapman, Cole G., Smith, Brian J., Button, Anna M., Chrischilles, Elizabeth A., Mezhir, James J.
Publicado no Ann Surg (2015)

Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by Δγ(1)34.5 Mutants of Herpes Simplex Virus 1

Por Smith, Kerrington D., Mezhir, James J., Bickenbach, Kai, Veerapong, Jula, Charron, Jean, Posner, Mitchell C., Roizman, Bernard, Weichselbaum, Ralph R.
Publicado em 2006

A prognostic nomogram for prediction of recurrence in desmoid fibromatosis

Por Crago, Aimeé M., Denton, Brian, Salas, Sébastien, Dufresne, Armelle, Mezhir, James J., Hameed, Meera, Gonen, Mithat, Singer, Samuel, Brennan, Murray F.
Publicado em 2013

Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells

Por Hrabe, Jennifer E., O’Leary, Brianne R., Fath, Melissa A., Rodman, Samuel N., Button, Anna M., Domann, Frederick E., Spitz, Douglas R., Mezhir, James J.
Publicado no Redox Biol (2015)

Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma

Por O’Leary, Brianne R., Houwen, Frederick K., Johnson, Chase L., Allen, Bryan G., Mezhir, James J., Berg, Daniel J., Cullen, Joseph J., Spitz, Douglas R.
Publicado no Radiat Res (2018)

Changes in the management of benign liver tumours: an analysis of 285 patients

Por Mezhir, James J, Fourman, Lindsay T, Do, Richard K, Denton, Brian, Allen, Peter J, D'Angelica, Michael I, DeMatteo, Ronald P, Fong, Yuman, Jarnagin, William R
Publicado em 2013

Pyogenic abscess after hepatic artery embolization: A rare but potentially lethal complication

Por Mezhir, James J., Fong, Yuman, Fleischer, Deborah, Seo, Susan K., D’Amico, Francesco, Petre, Elena, Covey, Ann M., Getrajdman, George I., Thornton, Raymond H., Solomon, Stephen B., Jarnagin, William R., Brown, Karen T.
Publicado no J Vasc Interv Radiol (2010)

RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients

Por Muniz, Viviane P., Askeland, Ryan W., Zhang, Xuefeng, Reed, Sara M., Tompkins, Van S., Hagen, Jussara, McDowell, Bradley D., Button, Anna, Smith, Brian J., Weydert, Jamie A., Mezhir, James J., Quelle, Dawn E.
Publicado em 2013

Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma

Por O’Leary, Brianne R., Fath, Melissa A., Bellizzi, Andrew M., Hrabe, Jennifer E., Button, Anna M., Allen, Bryan G., Case, Adam J., Altekruse, Sean, Wagner, Brett A., Buettner, Garry R., Lynch, Charles F., Hernandez, Brenda Y., Cozen, Wendy, Beardsley, Robert A., Keene, Jeffery, Henry, Michael D., Domann, Frederick E., Spitz, Douglas R., Mezhir, James J.
Publicado no Clin Cancer Res (2015)